Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Clinical trial NCT03634332 · UNKNOWN
Trial details
- NCT number
- NCT03634332
- Sponsor
- Pancreatic Cancer Research Team
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2020-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.